The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Monitoring, Immunologic

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Monitoring, Immunologic


High impact information on Monitoring, Immunologic

  • IL-13 can also inhibit tumor immunosurveillance [6].
  • These results demonstrate a role for FucT-IV in selectin-dependent adhesion and suggest that the endothelial selectins and FucTs have distinct but overlapping functions in the immunosurveillance of the skin [7].
  • NKG2D is an important immunosurveillance receptor that responds to stress-induced ligand expression on tumors and virus-infected cells [8].
  • Thus, NKG2D engagement is a natural mediator of immunosurveillance, which can be compromised by locally sustained ligand expression but potentially restored by innate immune activation [9].
  • NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway [10].

Chemical compound and disease context of Monitoring, Immunologic


Biological context of Monitoring, Immunologic


Anatomical context of Monitoring, Immunologic


Associations of Monitoring, Immunologic with chemical compounds


Gene context of Monitoring, Immunologic


Analytical, diagnostic and therapeutic context of Monitoring, Immunologic


  1. HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance. Paul, P., Rouas-Freiss, N., Khalil-Daher, I., Moreau, P., Riteau, B., Le Gal, F.A., Avril, M.F., Dausset, J., Guillet, J.G., Carosella, E.D. Proc. Natl. Acad. Sci. U.S.A. (1998) [Pubmed]
  2. The mutator pathway is a feature of immunodeficiency-related lymphomas. Duval, A., Raphael, M., Brennetot, C., Poirel, H., Buhard, O., Aubry, A., Martin, A., Krimi, A., Leblond, V., Gabarre, J., Davi, F., Charlotte, F., Berger, F., Gaidano, G., Capello, D., Canioni, D., Bordessoule, D., Feuillard, J., Gaulard, P., Delfau, M.H., Ferlicot, S., Eclache, V., Prevot, S., Guettier, C., Lefevre, P.C., Adotti, F., Hamelin, R. Proc. Natl. Acad. Sci. U.S.A. (2004) [Pubmed]
  3. HLA-G protein up-regulation in primary cutaneous lymphomas is associated with interleukin-10 expression in large cell T-cell lymphomas and indolent B-cell lymphomas. Urosevic, M., Willers, J., Mueller, B., Kempf, W., Burg, G., Dummer, R. Blood (2002) [Pubmed]
  4. A model for CD8+ CTL tumor immunosurveillance and regulation of tumor escape by CD4 T cells through an effect on quality of CTL. Matsui, S., Ahlers, J.D., Vortmeyer, A.O., Terabe, M., Tsukui, T., Carbone, D.P., Liotta, L.A., Berzofsky, J.A. J. Immunol. (1999) [Pubmed]
  5. Wild-derived inbred mice have a novel basis of susceptibility to polyomavirus-induced tumors. Velupillai, P., Yoshizawa, I., Dey, D.C., Nahill, S.R., Carroll, J.P., Bronson, R.T., Benjamin, T.L. J. Virol. (1999) [Pubmed]
  6. IL-13 effector functions. Wynn, T.A. Annu. Rev. Immunol. (2003) [Pubmed]
  7. Specialized contributions by alpha(1,3)-fucosyltransferase-IV and FucT-VII during leukocyte rolling in dermal microvessels. Weninger, W., Ulfman, L.H., Cheng, G., Souchkova, N., Quackenbush, E.J., Lowe, J.B., von Andrian, U.H. Immunity (2000) [Pubmed]
  8. NKG2D-mediated signaling requires a DAP10-bound Grb2-Vav1 intermediate and phosphatidylinositol-3-kinase in human natural killer cells. Upshaw, J.L., Arneson, L.N., Schoon, R.A., Dick, C.J., Billadeau, D.D., Leibson, P.J. Nat. Immunol. (2006) [Pubmed]
  9. Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance. Oppenheim, D.E., Roberts, S.J., Clarke, S.L., Filler, R., Lewis, J.M., Tigelaar, R.E., Girardi, M., Hayday, A.C. Nat. Immunol. (2005) [Pubmed]
  10. NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway. Terabe, M., Matsui, S., Noben-Trauth, N., Chen, H., Watson, C., Donaldson, D.D., Carbone, D.P., Paul, W.E., Berzofsky, J.A. Nat. Immunol. (2000) [Pubmed]
  11. The effect of cadmium on chemical- and viral-induced tumor production in mice. Blakley, B.R. Journal of applied toxicology : JAT. (1986) [Pubmed]
  12. Molecular characterization of novel H-2 class I molecules expressed by a C3H UV-induced fibrosarcoma. McMillan, M., Lewis, K.D., Rovner, D.M. Proc. Natl. Acad. Sci. U.S.A. (1985) [Pubmed]
  13. Role of transforming growth factor Beta in human cancer. Elliott, R.L., Blobe, G.C. J. Clin. Oncol. (2005) [Pubmed]
  14. TGF-beta-based immunotherapy for cancer: breaching the tumor firewall. Shah, A.H., Lee, C. Prostate (2000) [Pubmed]
  15. Selective expression of the interleukin-2 gene discriminates between the auto- and allo-mixed lymphocyte reaction. Moudgil, A., Toyoda, M., Galfayan, K., Jordan, S.C. Transpl. Immunol. (1997) [Pubmed]
  16. Susceptibility to tumors induced by polyoma virus is conferred by an endogenous mouse mammary tumor virus superantigen. Lukacher, A.E., Ma, Y., Carroll, J.P., Abromson-Leeman, S.R., Laning, J.C., Dorf, M.E., Benjamin, T.L. J. Exp. Med. (1995) [Pubmed]
  17. Transforming growth factor-beta production and myeloid cells are an effector mechanism through which CD1d-restricted T cells block cytotoxic T lymphocyte-mediated tumor immunosurveillance: abrogation prevents tumor recurrence. Terabe, M., Matsui, S., Park, J.M., Mamura, M., Noben-Trauth, N., Donaldson, D.D., Chen, W., Wahl, S.M., Ledbetter, S., Pratt, B., Letterio, J.J., Paul, W.E., Berzofsky, J.A. J. Exp. Med. (2003) [Pubmed]
  18. T-cell interaction with ICAM-1/ICAM-2 double-deficient brain endothelium in vitro: the cytoplasmic tail of endothelial ICAM-1 is necessary for transendothelial migration of T cells. Lyck, R., Reiss, Y., Gerwin, N., Greenwood, J., Adamson, P., Engelhardt, B. Blood (2003) [Pubmed]
  19. Activation of interleukin-13 expression in T cells from HTLV-1-infected individuals and in chronically infected cell lines. Chung, H.K., Young, H.A., Goon, P.K., Heidecker, G., Princler, G.L., Shimozato, O., Taylor, G.P., Bangham, C.R., Derse, D. Blood (2003) [Pubmed]
  20. In vivo expression of Toll-like receptor 2 and 4 by renal epithelial cells: IFN-gamma and TNF-alpha mediated up-regulation during inflammation. Wolfs, T.G., Buurman, W.A., van Schadewijk, A., de Vries, B., Daemen, M.A., Hiemstra, P.S., van 't Veer, C. J. Immunol. (2002) [Pubmed]
  21. A randomized trial of three renal transplant induction antibodies: early comparison of tacrolimus, mycophenolate mofetil, and steroid dosing, and newer immune-monitoring. Ciancio, G., Burke, G.W., Gaynor, J.J., Carreno, M.R., Cirocco, R.E., Mathew, J.M., Mattiazzi, A., Cordovilla, T., Roth, D., Kupin, W., Rosen, A., Esquenazi, V., Tzakis, A.G., Miller, J. Transplantation (2005) [Pubmed]
  22. Role of interleukin 2 receptors in immunologic monitoring following cardiac transplantation. Roodman, S.T., Miller, L.W., Tsai, C.C. Transplantation (1988) [Pubmed]
  23. Immunosurveillance of childhood ALL: polymorphic interferon-gamma alleles are associated with age at diagnosis and clinical risk groups. Cloppenborg, T., Stanulla, M., Zimmermann, M., Schrappe, M., Welte, K., Klein, C. Leukemia (2005) [Pubmed]
  24. Ifosfamide and cyclophosphamide: effects on immunosurveillance. Binotto, G., Trentin, L., Semenzato, G. Oncology (2003) [Pubmed]
  25. Recombinant tumor-associated MUC1 glycoprotein impairs the differentiation and function of dendritic cells. Rughetti, A., Pellicciotta, I., Biffoni, M., Bäckström, M., Link, T., Bennet, E.P., Clausen, H., Noll, T., Hansson, G.C., Burchell, J.M., Frati, L., Taylor-Papadimitriou, J., Nuti, M. J. Immunol. (2005) [Pubmed]
  26. E-selectin, thymus- and activation-regulated chemokine/CCL17, and intercellular adhesion molecule-1 are constitutively coexpressed in dermal microvessels: a foundation for a cutaneous immunosurveillance system. Chong, B.F., Murphy, J.E., Kupper, T.S., Fuhlbrigge, R.C. J. Immunol. (2004) [Pubmed]
  27. Identification of the osteopontin gene as a direct target of TP53. Morimoto, I., Sasaki, Y., Ishida, S., Imai, K., Tokino, T. Genes Chromosomes Cancer (2002) [Pubmed]
  28. Signal transducer and activator of transcription 6 (Stat6) and CD1: inhibitors of immunosurveillance against primary tumors and metastatic disease. Ostrand-Rosenberg, S., Sinha, P., Clements, V., Dissanayake, S.I., Miller, S., Davis, C., Danna, E. Cancer Immunol. Immunother. (2004) [Pubmed]
  29. Contributions of direct and indirect T cell alloreactivity during allograft rejection in mice. Benichou, G., Valujskikh, A., Heeger, P.S. J. Immunol. (1999) [Pubmed]
  30. Antibodies against early proteins of human papillomaviruses as diagnostic markers for invasive cervical cancer. Meschede, W., Zumbach, K., Braspenning, J., Scheffner, M., Benitez-Bribiesca, L., Luande, J., Gissmann, L., Pawlita, M. J. Clin. Microbiol. (1998) [Pubmed]
  31. HLA-G is expressed by the glandular epithelium of peritoneal endometriosis but not in eutopic endometrium. Barrier, B.F., Kendall, B.S., Ryan, C.E., Sharpe-Timms, K.L. Hum. Reprod. (2006) [Pubmed]
  32. Measurement of interferon-gamma by high-throughput fluorometric microvolume assay technology system. Komatsu, N., Shichijo, S., Maeda, Y., Itoh, K. J. Immunol. Methods (2002) [Pubmed]
WikiGenes - Universities